H.I.G. Capital Makes Strategic Equity Investment in Rising Pharmaceuticals
December 13, 2021
An affiliate of H.I.G. Capital has made a strategic equity investment in Rising Pharma Holdings and Casper Pharma (together, Rising Pharmaceuticals) to support the company's growth, M&A activity and new product launches. Rising Pharmaceuticals is an asset-light developer and marketer of generic and specialty pharmaceuticals based in New Jersey with a diversified portfolio of over 125 products and a network of 23+ CMO/CDO partners.
- Buyers
- H.I.G. Capital
- Targets
- Rising Pharma Holdings, Casper Pharma
- Industry
- Pharmaceuticals
- Location
- New Jersey, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
H.I.G. Capital Makes Strategic Growth Investment in HBK
August 25, 2026
Accounting & Tax
H.I.G. Capital, through an affiliate, agreed to make a strategic growth investment in HBK, an integrated accounting, tax, audit, consulting, technology, and wealth management firm, establishing H.I.G. as HBK’s first institutional partner. HBK partners will continue to lead the firm, with the deal expected to close in Q4 2026 subject to customary regulatory approvals and closing conditions.
-
1315 Capital Backs USpharma Ltd. with Growth Equity Investment
June 30, 2025
Pharmaceuticals
USpharma Ltd., a Miami Lakes-based pharmaceutical development and manufacturing company, received a growth equity investment from Philadelphia-based 1315 Capital. The capital will be used to accelerate development and commercialization of USpharma’s pipeline, expand commercial reach, and scale operations at its 150,000 sq. ft. US-based GMP facility.
-
H.I.G. Capital Acquires ITH Group Limited
June 13, 2025
Healthcare Services
H.I.G. Capital (via an affiliate) has completed the acquisition of ITH Group Limited, a UK-based provider of aseptic pharmaceutical compounding services. Financial terms were not disclosed; ITH's founders Adam Bloom and Karen Hamling will remain in management as H.I.G. supports organic growth and increased production capacity.
-
H.I.G. Capital Makes Strategic Growth Investment in 3Pillar Global
November 23, 2021
Software
H.I.G. Capital (through an affiliate) made a strategic growth investment in 3Pillar Global, a global software product development firm. The investment will support 3Pillar's continued scaling, talent attraction and development, and expansion of its digital product engineering capabilities.
-
H.I.G. Capital Acquires Aspire Pharma Limited
September 24, 2021
Pharmaceuticals
An affiliate of H.I.G. Capital has acquired Aspire Pharma Limited, a UK-based developer and licensor of niche generic and branded specialty pharmaceuticals. Founder Graham Fraser-Pye remains with the business as chairman; financial terms were not disclosed and H.I.G. said it will support Aspire's organic growth, M&A activity and international expansion.
-
H.I.G. Capital Makes $225M Strategic Minority Investment in eHealth, Inc.
May 17, 2021
Healthcare Services
An affiliate of H.I.G. Capital completed a $225 million strategic minority investment in eHealth, Inc. via convertible preferred stock. The capital will be used to accelerate eHealth's growth, expand scale and market share, and fast-track the company's strategic initiatives for its online health insurance marketplace.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.